We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Advanced Medical Solutions Group Plc | LSE:AMS | London | Ordinary Share | GB0004536594 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.80 | -0.43% | 185.80 | 185.60 | 187.00 | 188.80 | 185.20 | 187.40 | 272,263 | 16:35:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Plastics,resins,elastomers | 126.21M | 15.89M | 0.0732 | 25.44 | 404.45M |
TIDMAMS
RNS Number : 1032C
Advanced Medical Solutions Grp PLC
10 April 2017
10 April 2017
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Director/PDMR and PCA Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and advanced wound care markets, announces that the Board, following a recommendation from the Remuneration Committee, has granted new share options to the following Directors and PDMRs under the Advanced Medical Solutions Long Term Incentive Plan (the 'LTIP') on 6 April 2017. The vesting period of these options is subject to certain performance criteria over a three year period.
Director/PDMR Options prior Options granted Resultant to grant holding ================== ============== ================ ========== Chris Meredith Chief Executive Officer 968,436 109,571 1,078,007 ================== ============== ================ ========== Mary Tavener Chief Financial Officer 591,199 84,762 675,961 ================== ============== ================ ========== Simon Coates PDMR 91,864 17,891 109,755 ================== ============== ================ ========== Rose Guang PDMR 138,011 24,067 162,078 ================== ============== ================ ========== Eddie Johnson PDMR 120,364 23,775 144,139 ================== ============== ================ ========== Pieter van Hoof PDMR 121,505 23,428 144,933 ================== ============== ================ ========== Becky Walmsley PDMR 50,000 23,082 73,082 ================== ============== ================ ========== Jeff Willis PDMR 132,044 40,550 172,594 ================== ============== ================ ==========
Advanced Medical Solutions Group plc also announces that on 6 April 2017, the Board, following a recommendation from the Remuneration Committee, granted new share options to the following Directors under the Advanced Medical Solutions Deferred Annual Bonus Plan (the '2014 DAB').
This award is in respect of the part of their bonus that the Directors and PDMRs are compulsorily required to defer for the 2016 financial year. These options vest at the end of three years.
Director/PDMR Options prior Options granted Resultant to grant holding ================== ============== ================ ========== Chris Meredith Chief Executive Officer 82,218 23,369 105,587 ================== ============== ================ ========== Mary Tavener Chief Financial Officer 57,870 15,065 72,935 ================== ============== ================ ========== Simon Coates PDMR 4,438 3,306 7,744 ================== ============== ================ ========== Rose Guang PDMR 12,586 4,612 17,198 ================== ============== ================ ========== Eddie Johnson PDMR 14,803 4,556 19,359 ================== ============== ================ ========== Pieter van Hoof PDMR 13,490 4,329 17,819 ================== ============== ================ ========== Becky Walmsley PDMR 1,067 4,114 5,181 ================== ============== ================ ========== Jeff Willis PDMR 17,996 5,535 23,531 ================== ============== ================ ==========
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. Details of the person discharging managerial responsibilities/person closely associated --- --------------------------------------------------------------- a) Name: Chris Meredith --- --------------------------------------------------------------- 2. Reason for the notification --- --------------------------------------------------------------- a) Position/status: Director/PDMR --- --------------------------------------------------------------- b) Initial notification/Amendment: Initial Notification --- --------------------------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- --------------------------------------------------------------- a) Name: Advanced Medical Solutions Group plc --- --------------------------------------------------------------- b) LEI: 213800HJP6OWOSZI1L74 --- --------------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- --------------------------------------------------------------- a) Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 --- --------------------------------------------------------------- b) Nature of the transactions: * Grant of 109,571 options under the Advanced Medical Solutions Long Term Incentive Plan on 6 April 2017 * Grant of 23,369 options under the Advanced Medical Solutions Deferred Annual Bonus Plan on 6 April 2017 --- --------------------------------------------------------------- c) Price(s) and volume(s): Sale of shares: Price(s) Volume(s) --------- ---------- n/a n/a --------- ---------- --- --------------------------------------------------------------- d) Aggregated information: (Relates to those shares sold only) Aggregated volume: n/a Aggregated price: n/a --- --------------------------------------------------------------- e) Date of the transaction: 06/04/2017 --- --------------------------------------------------------------- f) Place of the transaction: London Stock Exchange, AIM Market (XLON) --- --------------------------------------------------------------- 1. Details of the person discharging managerial responsibilities/person closely associated --- --------------------------------------------------------------- a) Name: Mary Tavener --- --------------------------------------------------------------- 2. Reason for the notification --- --------------------------------------------------------------- a) Position/status: Director/PDMR --- --------------------------------------------------------------- b) Initial notification/Amendment: Initial Notification --- --------------------------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- --------------------------------------------------------------- a) Name: Advanced Medical Solutions Group plc --- --------------------------------------------------------------- b) LEI: 213800HJP6OWOSZI1L74 --- --------------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- --------------------------------------------------------------- a) Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 --- --------------------------------------------------------------- b) Nature of the transactions: * Grant of 84,762 options under the Advanced Medical Solutions Long Term Incentive Plan on 6 April 2017 * Grant of 15,065 options under the Advanced Medical Solutions Deferred Annual Bonus Plan on 6 April 2017 --- --------------------------------------------------------------- c) Price(s) and volume(s): Sale of shares: Price(s) Volume(s) --------- ---------- n/a n/a --------- ---------- --- --------------------------------------------------------------- d) Aggregated information: (Relates to those shares sold only) Aggregated volume: n/a Aggregated price: n/a --- --------------------------------------------------------------- e) Date of the transaction: 06/04/2017 --- --------------------------------------------------------------- f) Place of the transaction: London Stock Exchange, AIM Market (XLON) --- --------------------------------------------------------------- 1. Details of the person discharging managerial responsibilities/person closely associated --- --------------------------------------------------------------- a) Name: Simon Coates --- --------------------------------------------------------------- 2. Reason for the notification --- --------------------------------------------------------------- a) Position/status: Director/PDMR --- ---------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification --- --------------------------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- --------------------------------------------------------------- a) Name: Advanced Medical Solutions Group plc --- --------------------------------------------------------------- b) LEI: 213800HJP6OWOSZI1L74 --- --------------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- --------------------------------------------------------------- a) Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 --- --------------------------------------------------------------- b) Nature of the transactions: * Grant of 17,891 options under the Advanced Medical Solutions Long Term Incentive Plan on 6 April 2017 * Grant of 3,306 options under the Advanced Medical Solutions Deferred Annual Bonus Plan on 6 April 2017 --- --------------------------------------------------------------- c) Price(s) and volume(s): Sale of shares: Price(s) Volume(s) --------- ---------- n/a n/a --------- ---------- --- --------------------------------------------------------------- d) Aggregated information: (Relates to those shares sold only) Aggregated volume: n/a Aggregated price: n/a --- --------------------------------------------------------------- e) Date of the transaction: 06/04/2017 --- --------------------------------------------------------------- f) Place of the transaction: London Stock Exchange, AIM Market (XLON) --- --------------------------------------------------------------- 1. Details of the person discharging managerial responsibilities/person closely associated --- --------------------------------------------------------------- a) Name: Rose Guang --- --------------------------------------------------------------- 2. Reason for the notification --- --------------------------------------------------------------- a) Position/status: Director/PDMR --- --------------------------------------------------------------- b) Initial notification/Amendment: Initial Notification --- --------------------------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- --------------------------------------------------------------- a) Name: Advanced Medical Solutions Group plc --- --------------------------------------------------------------- b) LEI: 213800HJP6OWOSZI1L74 --- --------------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- --------------------------------------------------------------- a) Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 --- --------------------------------------------------------------- b) Nature of the transactions: * Grant of 24,067 options under the Advanced Medical Solutions Long Term Incentive Plan on 6 April 2017 * Grant of 4,612 options under the Advanced Medical Solutions Deferred Annual Bonus Plan on 6 April 2017 --- --------------------------------------------------------------- c) Price(s) and volume(s): Sale of shares: Price(s) Volume(s) --------- ---------- n/a n/a --------- ---------- --- --------------------------------------------------------------- d) Aggregated information: (Relates to those shares sold only) Aggregated volume: n/a Aggregated price: n/a --- --------------------------------------------------------------- e) Date of the transaction: 06/04/2017 --- --------------------------------------------------------------- f) Place of the transaction: London Stock Exchange, AIM Market (XLON) --- --------------------------------------------------------------- 1. Details of the person discharging managerial responsibilities/person closely associated --- --------------------------------------------------------------- a) Name: Eddie Johnson --- --------------------------------------------------------------- 2. Reason for the notification --- --------------------------------------------------------------- a) Position/status: Director/PDMR --- --------------------------------------------------------------- b) Initial notification/Amendment: Initial Notification --- --------------------------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- --------------------------------------------------------------- a) Name: Advanced Medical Solutions Group plc --- --------------------------------------------------------------- b) LEI: 213800HJP6OWOSZI1L74 --- --------------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- --------------------------------------------------------------- a) Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 --- --------------------------------------------------------------- b) Nature of the transactions: * Grant of 23,775 options under the Advanced Medical Solutions Long Term Incentive Plan on 6 April 2017 * Grant of 4,556 options under the Advanced Medical Solutions Deferred Annual Bonus Plan on 6 April 2017 --- --------------------------------------------------------------- c) Price(s) and volume(s): Sale of shares: Price(s) Volume(s) --------- ---------- n/a n/a --------- ---------- --- --------------------------------------------------------------- d) Aggregated information: (Relates to those shares sold only) Aggregated volume: n/a Aggregated price: n/a --- --------------------------------------------------------------- e) Date of the transaction: 06/04/2017 --- --------------------------------------------------------------- f) Place of the transaction: London Stock Exchange, AIM Market (XLON) --- --------------------------------------------------------------- 1. Details of the person discharging managerial responsibilities/person closely associated --- --------------------------------------------------------------- a) Name: Pieter van Hoof --- --------------------------------------------------------------- 2. Reason for the notification --- --------------------------------------------------------------- a) Position/status: Director/PDMR --- --------------------------------------------------------------- b) Initial notification/Amendment: Initial Notification --- --------------------------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- --------------------------------------------------------------- a) Name: Advanced Medical Solutions Group plc --- --------------------------------------------------------------- b) LEI: 213800HJP6OWOSZI1L74 --- --------------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- --------------------------------------------------------------- a) Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 --- --------------------------------------------------------------- b) Nature of the transactions: * Grant of 23,428 options under the Advanced Medical Solutions Long Term Incentive Plan on 6 April 2017 * Grant of 4,329 options under the Advanced Medical Solutions Deferred Annual Bonus Plan on 6 April 2017 --- --------------------------------------------------------------- c) Price(s) and volume(s): Sale of shares: Price(s) Volume(s) --------- ---------- n/a n/a --------- ---------- --- --------------------------------------------------------------- d) Aggregated information: (Relates to those shares sold only) Aggregated volume: n/a Aggregated price: n/a --- --------------------------------------------------------------- e) Date of the transaction: 06/04/2017 --- --------------------------------------------------------------- f) Place of the transaction: London Stock Exchange, AIM Market (XLON) --- ---------------------------------------------------------------
1. Details of the person discharging managerial responsibilities/person closely associated --- --------------------------------------------------------------- a) Name: Becky Walmsley --- --------------------------------------------------------------- 2. Reason for the notification --- --------------------------------------------------------------- a) Position/status: Director/PDMR --- --------------------------------------------------------------- b) Initial notification/Amendment: Initial Notification --- --------------------------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- --------------------------------------------------------------- a) Name: Advanced Medical Solutions Group plc --- --------------------------------------------------------------- b) LEI: 213800HJP6OWOSZI1L74 --- --------------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- --------------------------------------------------------------- a) Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 --- --------------------------------------------------------------- b) Nature of the transactions: * Grant of 23,082 options under the Advanced Medical Solutions Long Term Incentive Plan on 6 April 2017 * Grant of 4,114 options under the Advanced Medical Solutions Deferred Annual Bonus Plan on 6 April 2017 --- --------------------------------------------------------------- c) Price(s) and volume(s): Sale of shares: Price(s) Volume(s) --------- ---------- n/a n/a --------- ---------- --- --------------------------------------------------------------- d) Aggregated information: (Relates to those shares sold only) Aggregated volume: n/a Aggregated price: n/a --- --------------------------------------------------------------- e) Date of the transaction: 06/04/2017 --- --------------------------------------------------------------- f) Place of the transaction: London Stock Exchange, AIM Market (XLON) --- --------------------------------------------------------------- 1. Details of the person discharging managerial responsibilities/person closely associated --- --------------------------------------------------------------- a) Name: Jeff Willis --- --------------------------------------------------------------- 2. Reason for the notification --- --------------------------------------------------------------- a) Position/status: Director/PDMR --- --------------------------------------------------------------- b) Initial notification/Amendment: Initial Notification --- --------------------------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- --------------------------------------------------------------- a) Name: Advanced Medical Solutions Group plc --- --------------------------------------------------------------- b) LEI: 213800HJP6OWOSZI1L74 --- --------------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- --------------------------------------------------------------- a) Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 --- --------------------------------------------------------------- b) Nature of the transactions: * Grant of 40,550 options under the Advanced Medical Solutions Long Term Incentive Plan on 6 April 2017 * Grant of 5,535 options under the Advanced Medical Solutions Deferred Annual Bonus Plan on 6 April 2017 --- --------------------------------------------------------------- c) Price(s) and volume(s): Sale of shares: Price(s) Volume(s) --------- ---------- n/a n/a --------- ---------- --- --------------------------------------------------------------- d) Aggregated information: (Relates to those shares sold only) Aggregated volume: n/a Aggregated price: n/a --- --------------------------------------------------------------- e) Date of the transaction: 06/04/2017 --- --------------------------------------------------------------- f) Place of the transaction: London Stock Exchange, AIM Market (XLON) --- ---------------------------------------------------------------
- End -
For further information, please visit www.admedsol.com or contact:
Advanced Medical Solutions Group Tel: +44 (0) plc 1606 545508 Chris Meredith, Chief Executive Officer Mary Tavener, Chief Financial Officer Consilium Strategic Communications Tel: +44 (0) 20 3709 5700 Mary-Jane Elliott / Jonathan AMS@consilium-comms.com Birt / Matthew Neal / Hendrik Thys Investec Bank PLC (NOMAD & Broker) Tel: +44 (0) 20 7597 5970 Daniel Adams / Patrick Robb
About Advanced Medical Solutions Group plc - see www.admedsol.com
AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and advanced wound care markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of wound care products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it sells under white label as well as its own brand ActivHeal(R) , and surgical tissue adhesives, sutures and haemostats, which markets under its own brands; LiquiBand(R) and RESORBA(R) .
AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Company has 600 employees. For more information, please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBSGDSXDBBGRG
(END) Dow Jones Newswires
April 10, 2017 10:26 ET (14:26 GMT)
1 Year Advanced Medical Solutions Chart |
1 Month Advanced Medical Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions